LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Craig, Kathrine Jane
Languages: English
Types: Doctoral thesis
Subjects: RC, RA
Approximately 170 million individuals worldwide have been diagnosed with Diabetes Mellitus and between 85--90% of the total population have Type 2 Diabetes Mellitus. Health care is facing an epidemic not only of Diabetes Mellitus but also of the consequence of the attendant morbidity including macro and micro diseases of the vascular system. Of particular interest for the purposes of this thesis, is the progression to nephropathy and development of cardiovascular risk of a proportion of this population and the investigation of strategies that may slow the decline to end stage renal failure and the need for renal replacement therapy or premature death due to cardiovascular disease. Initially, screening practice for microalbuminuria was altered, with patients being identified during their clinic visit, rather than retrospectively. In addition, data on blood pressure levels and antihypertensive agents prescription was collected and collated. Subsequently, a nurse specialist optimised the risk factor management of a cohort of patients with Diabetic Nephropathy using an algorithm driven evidenced based approach. Finally, analysis was undertaken of the factors that might contribute to the development of anaemia in diabetic nephropathy and hence to increased cardiovascular risk. The work described in this thesis demonstrates the inherent complexities of dealing with a problem that involves the maintenance of health within a system that has been set up primarily to deal with the consequences of illness.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • [14] Miettinen H, Lehto SS, Mahonen M, Niemela M, Haffner SM, Pyorala K, et al. Impact of diabetes on mortality after the first myocardial infarction. Diabetes Care. 1998;21:69-75.
    • [15] Ritz E, Stefanski A. Diabetic nephropathy in type II diabetes. Am J Kidney Dis. 1996;27(2): 167-94.
    • [16] Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med. 1999;341(15):1127-33.
    • [17] Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med. 1994;330(1):15-8.
    • [18] Hasslacher C, Ritz E, Wahl P, Michael C. Similar risks of nephropathy in patients with Type I or Type II diabetes mellitus. Nephrology Dialysis Transplantation. 1989;4:859-63.
    • [19] US Renal Data System. USRDS 1998 annual report. Bethesda,MD: The National Institutes of Health; 1998.
    • [20] Ansell D, Feest T, Tomson C, Williams AJ, Warwick G, et al. UK Renal Registry Report. Bristol, UK: UK Renal Registry;; 2006.
    • [21] UK prospective diabetes study group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. British Medical Journal. 1998;327:703-13. [28] Wolf G, Ziyadeh FN. Molecular mechanisms of diabetic renal hypertrophy. Kidney International. 1999;56:393.
    • [39] Poirier P, Giles T, Bray G, Hong Y, Stern J, Pi-Sunyer F, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Arteriosclerosis, Thrombosis & Vascular Biology. 2006;26(5):968-76.
    • [40] Ejerblad E, Fored CM, Lindblad P. Obesity and risk for chronic renal failure. Journal of the American Medical Association. 2006;17:1695.
    • [52] Mykkanen L, Zaccaro D, O 'Leary D, Howard G, Robbins D, Haffner S, et al. Microalbuminuria and carotid artery intima-media thickness in nondiabetic and NIDDM subjects. . Stroke. 1997;28:1710-6.
    • [53] Tuttle K, Puhlman M, Cooney S, Short R. Urinary albumin and insulin as predictors of coronary artery disease: an angiographic study. American Journal of Kidney Disease 1999;34:918-25.
    • [54] Abbate M, Benigni A, Bertani T, Remuzzi G. Nephrotoxicity of increased glomerular protein traffic. Nephrology Dialysis and Transplantation. 1999; 14(2):304-12.
    • [55] Parving HH, Gall MA, Skott P, Jorgensen HE, Lokkegaard H, Jorgensen F, et al. Prevalence and causes of albuminuria in non-insulindependent diabetic patients. Kidney Int. 1992;41(4):758-62.
    • [56] Williams JD, Coles GA. Proteinuria--a direct cause of renal morbidity? Kidney Int. 1994 45(2):443-50.
    • [57] de Zeeuw D. Albuminuria, not only a cardiovascular/renal risk marker, but also a target for treatment? Kidney International 2004 Nov(92):S2-6.
    • [64] Tonelli M, Sacks F, Pfeffer M, Lopez-Jimenez F, Jhangri GS, G. C. Effect of pravastatin on blood pressure in people with cardiovascular disease. J Hum Hypertens 2006;20(8):560-5.
    • [65] Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311(2):89-93.
    • [66] Dinneen SF, Gerstein HC. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature. Archives of Internal Medicine. 1997; 157(13): 1413-8.
    • [67] Tarnow L, Rossing P, Gall MA, Nielsen FS, Parving HH, Tarnow L, et al. Prevalence of arterial hypertension in diabetic patients before and after the JNC-V. Diabetes Care. 1994 Nov; 17(11): 1247-51.
    • [111] Parving HH. Diabetic nephropathy: Prevention and treatment. Kidney Int. 2001;60(5):2041 -55.
    • [112] Ruggenenti P, Fassi A, llieva AP, Bruno S, lliev IP, Brusegan V, et al. Preventing microalbuminuria in type 2 diabetes. N Engl J Med. 2004 Nov 4;351(19):1941-51.
    • [113] King H, Aubert RE, Herman WH. Global burden of diabetes, 1995- 2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21 (9): 1414-31.
    • [114] Groves T, Wagner EH. High quality care for people with chronic diseases. British Medical Journal. 2005;330(7492):609-10.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article